Differences in NMDA Receptor Expression During Human Development Determine the Response of Neurons to HIV-Tat-mediated Neurotoxicity

[1]  M. Bennett,et al.  HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes , 2007, Proceedings of the National Academy of Sciences.

[2]  Mijna Hadders-Algra,et al.  Ontogeny of the human central nervous system: what is happening when? , 2006, Early human development.

[3]  J. Berman,et al.  NeuroAIDS: Contributions of the human immunodeficiency virus‐1 proteins tat and gp120 as well as CD40 to microglial activation , 2005, Journal of neuroscience research.

[4]  J. McArthur.  HIV dementia: an evolving disease , 2004, Journal of Neuroimmunology.

[5]  H. Lagercrantz,et al.  Development of neurotransmitter systems during critical periods , 2004, Experimental Neurology.

[6]  S. Cull-Candy,et al.  Role of Distinct NMDA Receptor Subtypes at Central Synapses , 2004, Science's STKE.

[7]  J. Berman,et al.  MCP‐1 (CCL2) protects human neurons and astrocytes from NMDA or HIV‐tat‐induced apoptosis , 2003, Journal of neurochemistry.

[8]  E. Major,et al.  Lineage pathway of human brain progenitor cells identified by JC virus susceptability , 2003, Annals of neurology.

[9]  Andrew V. Albright,et al.  Pathogenesis of human immunodeficiency virus-induced neurological disease , 2003, Journal of NeuroVirology.

[10]  J. Berman,et al.  Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. , 2003, Methods.

[11]  J. Berman,et al.  TNF-α Plus IFN-γ Induce Connexin43 Expression and Formation of Gap Junctions Between Human Monocytes/Macrophages That Enhance Physiological Responses 1 , 2003, The Journal of Immunology.

[12]  N. Sacktor.  The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.

[13]  P. Mulholland,et al.  Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor , 2002, Brain Research.

[14]  D. Noonan,et al.  HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. , 2001, Biochemical and biophysical research communications.

[15]  H. Lagercrantz,et al.  Neurotransmitters and neuromodulators during early human development. , 2001, Early human development.

[16]  M Stürzl,et al.  Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. , 2001, Molecular biology of the cell.

[17]  M. Mattson,et al.  HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity , 2001, Journal of neurochemistry.

[18]  Y. Nishizawa,et al.  Glutamate release and neuronal damage in ischemia. , 2001, Life sciences.

[19]  J. Meador-Woodruff,et al.  Ontogeny of ionotropic glutamate receptor expression in human fetal brain. , 2001, Brain research. Developmental brain research.

[20]  Kevin K W Wang,et al.  Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture , 2001, Journal of NeuroVirology.

[21]  D. Corbett,et al.  HIV‐1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors , 2001, Annals of neurology.

[22]  R. Tanzi,et al.  Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands , 2000, Nature Medicine.

[23]  S. Woodman,et al.  Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. , 2000, The American journal of pathology.

[24]  Melina V Jones,et al.  Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine , 2000, Annals of neurology.

[25]  E. Ceballos,et al.  Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms , 1999, Oncogene.

[26]  B. Aggarwal,et al.  Human immunodeficiency virus‐1‐tat induces matrix metalloproteinase‐9 in monocytes through protein tyrosine phosphatase‐mediated activation of nuclear transcription factor NF‐κB , 1999 .

[27]  A. Nath,et al.  Involvement of Inositol 1,4,5‐Trisphosphate‐Regulated Stores of Intracellular Calcium in Calcium Dysregulation and Neuron Cell Death Caused by HIV‐1 Protein Tat , 1999, Journal of neurochemistry.

[28]  S. Croul,et al.  Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.

[29]  S. Bartz,et al.  Human Immunodeficiency Virus Type 1 Tat Induces Apoptosis and Increases Sensitivity to Apoptotic Signals by Up-Regulating FLICE/Caspase-8 , 1999, Journal of Virology.

[30]  F. Silverstein,et al.  Tat, a human immunodeficiency virus-1 derived protein, augments excitotoxic hippocampal injury in neonatal rats , 1999, Neuroscience.

[31]  M. Mattson,et al.  HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.

[32]  S. Manna,et al.  HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. , 1998, Journal of immunology.

[33]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[34]  A. Nath,et al.  Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms , 1998, Progress in Neurobiology.

[35]  A. Nath,et al.  Molecular Determinants for Cellular Uptake of Tat Protein of Human Immunodeficiency Virus Type 1 in Brain Cells , 1996 .

[36]  E. Major,et al.  Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes , 1996, Journal of virology.

[37]  C. Portera-Cailliau,et al.  N‐Methyl‐d‐Aspartate Receptor Proteins NR2A and NR2B Are Differentially Distributed in the Developing Rat Central Nervous System as Revealed by Subunit‐Specific Antibodies , 1996, Journal of neurochemistry.

[38]  R. Brownstone,et al.  Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity , 1995, Annals of neurology.

[39]  B. Sakmann,et al.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.

[40]  P. Wingfield,et al.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.

[41]  B. H. Choi,et al.  Density and distribution of excitatory amino acid receptors in the developing human fetal brain: A quantitative autoradiographic study , 1992, Experimental Neurology.

[42]  M. Johnston,et al.  Glutamate recognition sites in human fetal brain , 1988, Neuroscience Letters.

[43]  K. Conant,et al.  Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases , 2011, Journal of NeuroVirology.

[44]  E. Major,et al.  JC virus can infect human immune and nervous system progenitor cells: implications for pathogenesis. , 2006, Advances in experimental medicine and biology.

[45]  J. Joseph,et al.  NeuroAIDS in the developing world. , 2005, Journal of Neurovirology.

[46]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[47]  J. Berman,et al.  TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. , 2003, Journal of immunology.

[48]  B. Aggarwal,et al.  Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. , 1999, FEBS letters.

[49]  J. Karn,et al.  Tackling Tat. , 1999, Journal of molecular biology.

[50]  E. Vivés,et al.  Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. , 1991, Journal of virology.